Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose sequential chemotherapy + rituximab with autologous transplant vs R-CHOP-14 in high-risk diffuse large B-cell lymphoma
2005-000700-14Phase 3Completed
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Feb 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of rituximab in diffuse large B-cell lymphoma (DLBCL) (2 arms), sponsored by Papa Giovanni XXIII Hospital. Started Feb 2007; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2005-000700-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000700-14.